Concepts (184)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Infections | 13 | 2021 | 439 | 2.080 |
Why?
|
| Volatile Organic Compounds | 2 | 2023 | 8 | 0.820 |
Why?
|
| Fellowships and Scholarships | 1 | 2023 | 35 | 0.800 |
Why?
|
| Faculty, Nursing | 1 | 2023 | 39 | 0.780 |
Why?
|
| Parents | 3 | 2021 | 107 | 0.710 |
Why?
|
| Epidemics | 1 | 2021 | 1 | 0.690 |
Why?
|
| Nurse's Role | 2 | 2021 | 57 | 0.680 |
Why?
|
| Electronic Nose | 2 | 2023 | 3 | 0.680 |
Why?
|
| Breath Tests | 2 | 2023 | 10 | 0.680 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2019 | 104 | 0.670 |
Why?
|
| Patient Care | 1 | 2021 | 29 | 0.670 |
Why?
|
| Stress, Psychological | 3 | 2019 | 215 | 0.670 |
Why?
|
| Publications | 1 | 2020 | 13 | 0.630 |
Why?
|
| Biosensing Techniques | 1 | 2020 | 11 | 0.620 |
Why?
|
| Bayes Theorem | 1 | 2020 | 32 | 0.620 |
Why?
|
| Statistics as Topic | 1 | 2020 | 85 | 0.620 |
Why?
|
| Periodicals as Topic | 1 | 2020 | 31 | 0.600 |
Why?
|
| Parenting | 1 | 2019 | 67 | 0.580 |
Why?
|
| Immunosenescence | 1 | 2018 | 4 | 0.560 |
Why?
|
| Fish Oils | 1 | 2018 | 5 | 0.560 |
Why?
|
| Humans | 35 | 2023 | 23210 | 0.560 |
Why?
|
| Caregivers | 1 | 2019 | 192 | 0.520 |
Why?
|
| Cytokines | 1 | 2018 | 192 | 0.510 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2019 | 311 | 0.500 |
Why?
|
| Inflammation | 1 | 2018 | 230 | 0.490 |
Why?
|
| Antiretroviral Therapy, Highly Active | 4 | 2021 | 60 | 0.490 |
Why?
|
| Lung Neoplasms | 1 | 2020 | 539 | 0.440 |
Why?
|
| HIV Wasting Syndrome | 2 | 2013 | 4 | 0.430 |
Why?
|
| Anticholesteremic Agents | 2 | 2011 | 14 | 0.380 |
Why?
|
| Complementary Therapies | 1 | 2012 | 7 | 0.360 |
Why?
|
| Education, Nursing, Graduate | 1 | 2012 | 42 | 0.350 |
Why?
|
| Fatty Alcohols | 1 | 2011 | 5 | 0.340 |
Why?
|
| Mannans | 2 | 2013 | 5 | 0.340 |
Why?
|
| Medically Underserved Area | 1 | 2011 | 13 | 0.340 |
Why?
|
| Obesity | 3 | 2013 | 288 | 0.340 |
Why?
|
| Dyslipidemias | 1 | 2011 | 15 | 0.330 |
Why?
|
| Weight Loss | 3 | 2013 | 122 | 0.320 |
Why?
|
| Dietary Supplements | 5 | 2018 | 55 | 0.270 |
Why?
|
| Anesthesia | 2 | 2021 | 28 | 0.270 |
Why?
|
| Hyperlipidemias | 2 | 2004 | 17 | 0.260 |
Why?
|
| Double-Blind Method | 4 | 2018 | 374 | 0.260 |
Why?
|
| Anesthesia, General | 2 | 2019 | 23 | 0.250 |
Why?
|
| Female | 14 | 2023 | 13149 | 0.240 |
Why?
|
| Child, Preschool | 4 | 2021 | 570 | 0.240 |
Why?
|
| Anti-Obesity Agents | 1 | 2005 | 4 | 0.230 |
Why?
|
| Dietary Fiber | 1 | 2005 | 25 | 0.230 |
Why?
|
| Body Weight | 1 | 2005 | 129 | 0.230 |
Why?
|
| Middle Aged | 8 | 2019 | 7983 | 0.220 |
Why?
|
| Adult | 10 | 2019 | 6962 | 0.210 |
Why?
|
| Lipids | 1 | 2004 | 46 | 0.210 |
Why?
|
| Enteral Nutrition | 2 | 2004 | 60 | 0.210 |
Why?
|
| Insulin Resistance | 1 | 2004 | 48 | 0.210 |
Why?
|
| Male | 11 | 2019 | 12665 | 0.210 |
Why?
|
| United States | 4 | 2019 | 1804 | 0.210 |
Why?
|
| Monitoring, Physiologic | 1 | 2004 | 64 | 0.200 |
Why?
|
| Nonlinear Dynamics | 1 | 2023 | 11 | 0.200 |
Why?
|
| Hospitalization | 2 | 2016 | 288 | 0.190 |
Why?
|
| Arginine | 1 | 2002 | 17 | 0.190 |
Why?
|
| Immunity | 1 | 2002 | 10 | 0.190 |
Why?
|
| Adolescent | 4 | 2019 | 1884 | 0.190 |
Why?
|
| Sensitivity and Specificity | 2 | 2023 | 445 | 0.190 |
Why?
|
| Advance Care Planning | 1 | 2022 | 10 | 0.190 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2002 | 42 | 0.180 |
Why?
|
| Racism | 1 | 2022 | 27 | 0.180 |
Why?
|
| Child | 3 | 2021 | 1160 | 0.180 |
Why?
|
| Nursing Services | 1 | 2021 | 1 | 0.170 |
Why?
|
| Patient Satisfaction | 2 | 2014 | 257 | 0.170 |
Why?
|
| Exercise | 3 | 2021 | 404 | 0.170 |
Why?
|
| Health Literacy | 1 | 2022 | 87 | 0.170 |
Why?
|
| Nursing Research | 1 | 2021 | 32 | 0.170 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2023 | 220 | 0.160 |
Why?
|
| Organizational Innovation | 1 | 2020 | 11 | 0.160 |
Why?
|
| Exhalation | 1 | 2020 | 3 | 0.160 |
Why?
|
| Physical Fitness | 1 | 2020 | 48 | 0.160 |
Why?
|
| Respiratory Tract Infections | 1 | 2019 | 23 | 0.150 |
Why?
|
| Decision Making | 1 | 2021 | 179 | 0.150 |
Why?
|
| Cholesterol, HDL | 3 | 2011 | 26 | 0.150 |
Why?
|
| Cholesterol, LDL | 3 | 2011 | 29 | 0.150 |
Why?
|
| Triglycerides | 3 | 2011 | 54 | 0.150 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2018 | 16 | 0.140 |
Why?
|
| Midwestern United States | 1 | 2018 | 46 | 0.140 |
Why?
|
| Breast Feeding | 1 | 2019 | 139 | 0.140 |
Why?
|
| Milk, Human | 1 | 2019 | 157 | 0.130 |
Why?
|
| Cognition | 2 | 2021 | 1026 | 0.130 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 778 | 0.130 |
Why?
|
| Depression | 1 | 2020 | 383 | 0.130 |
Why?
|
| Police | 1 | 2016 | 2 | 0.130 |
Why?
|
| Prisoners | 1 | 2016 | 10 | 0.120 |
Why?
|
| Biomarkers | 1 | 2018 | 485 | 0.120 |
Why?
|
| Treatment Failure | 2 | 2013 | 126 | 0.110 |
Why?
|
| Prevalence | 2 | 2013 | 380 | 0.100 |
Why?
|
| Perioperative Nursing | 1 | 2014 | 3 | 0.100 |
Why?
|
| Cognition Disorders | 1 | 2019 | 726 | 0.100 |
Why?
|
| Cathartics | 1 | 2013 | 7 | 0.100 |
Why?
|
| Nurse-Patient Relations | 1 | 2014 | 43 | 0.100 |
Why?
|
| Physician-Patient Relations | 1 | 2014 | 36 | 0.100 |
Why?
|
| Military Personnel | 1 | 2014 | 37 | 0.100 |
Why?
|
| Models, Statistical | 1 | 2014 | 116 | 0.100 |
Why?
|
| Severity of Illness Index | 2 | 2019 | 804 | 0.100 |
Why?
|
| Body Composition | 3 | 2013 | 66 | 0.090 |
Why?
|
| Cross-Over Studies | 1 | 2011 | 64 | 0.080 |
Why?
|
| Pilot Projects | 3 | 2017 | 369 | 0.080 |
Why?
|
| HIV-Associated Lipodystrophy Syndrome | 1 | 2009 | 1 | 0.080 |
Why?
|
| Treatment Outcome | 6 | 2009 | 2943 | 0.070 |
Why?
|
| Infant | 2 | 2019 | 483 | 0.070 |
Why?
|
| Cholesterol | 2 | 2004 | 58 | 0.060 |
Why?
|
| Quality of Life | 2 | 2022 | 564 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 315 | 0.060 |
Why?
|
| Seroepidemiologic Studies | 1 | 2004 | 18 | 0.050 |
Why?
|
| Sample Size | 1 | 2004 | 17 | 0.050 |
Why?
|
| Fasting | 1 | 2004 | 22 | 0.050 |
Why?
|
| Clinical Trials as Topic | 1 | 2005 | 192 | 0.050 |
Why?
|
| Insulin | 1 | 2004 | 77 | 0.050 |
Why?
|
| Pneumonia, Aspiration | 1 | 2004 | 7 | 0.050 |
Why?
|
| Equipment Failure | 1 | 2004 | 34 | 0.050 |
Why?
|
| Blood Glucose | 1 | 2004 | 104 | 0.050 |
Why?
|
| Sex Characteristics | 1 | 2004 | 91 | 0.050 |
Why?
|
| Hot Flashes | 1 | 2003 | 11 | 0.050 |
Why?
|
| Plant Preparations | 1 | 2003 | 7 | 0.050 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2004 | 95 | 0.050 |
Why?
|
| Phytotherapy | 1 | 2003 | 11 | 0.050 |
Why?
|
| Adaptation, Psychological | 2 | 2020 | 168 | 0.050 |
Why?
|
| Social Problems | 1 | 2023 | 6 | 0.050 |
Why?
|
| Low Back Pain | 1 | 2004 | 129 | 0.050 |
Why?
|
| Food Technology | 1 | 2002 | 1 | 0.050 |
Why?
|
| Food, Genetically Modified | 1 | 2002 | 1 | 0.050 |
Why?
|
| Aged | 4 | 2021 | 7661 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 1 | 2004 | 235 | 0.050 |
Why?
|
| Pain Measurement | 1 | 2004 | 412 | 0.050 |
Why?
|
| RNA, Viral | 1 | 2002 | 44 | 0.050 |
Why?
|
| Cell Count | 1 | 2002 | 71 | 0.050 |
Why?
|
| Placebos | 1 | 2002 | 63 | 0.050 |
Why?
|
| Personal Satisfaction | 1 | 2022 | 39 | 0.050 |
Why?
|
| Killer Cells, Natural | 1 | 2002 | 40 | 0.050 |
Why?
|
| HIV | 1 | 2002 | 40 | 0.050 |
Why?
|
| Food, Formulated | 1 | 2002 | 3 | 0.050 |
Why?
|
| Health Status Disparities | 1 | 2022 | 66 | 0.040 |
Why?
|
| Healthcare Disparities | 1 | 2022 | 72 | 0.040 |
Why?
|
| Health Personnel | 1 | 2022 | 81 | 0.040 |
Why?
|
| Biological Products | 1 | 2002 | 31 | 0.040 |
Why?
|
| Grounded Theory | 1 | 2021 | 4 | 0.040 |
Why?
|
| Qualitative Research | 1 | 2021 | 94 | 0.040 |
Why?
|
| Self Report | 1 | 2021 | 202 | 0.040 |
Why?
|
| Body Mass Index | 2 | 2013 | 381 | 0.040 |
Why?
|
| Dementia | 1 | 2004 | 416 | 0.040 |
Why?
|
| Nurse Anesthetists | 1 | 2019 | 2 | 0.040 |
Why?
|
| Mothers | 1 | 2021 | 160 | 0.040 |
Why?
|
| Acute Disease | 1 | 2019 | 163 | 0.040 |
Why?
|
| Animals | 1 | 2005 | 3302 | 0.040 |
Why?
|
| Longitudinal Studies | 2 | 2017 | 1106 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2019 | 537 | 0.030 |
Why?
|
| Incidence | 1 | 2019 | 633 | 0.030 |
Why?
|
| Lymphocyte Count | 1 | 2017 | 16 | 0.030 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2017 | 13 | 0.030 |
Why?
|
| Risk | 1 | 2017 | 166 | 0.030 |
Why?
|
| Prisons | 1 | 2016 | 8 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2017 | 210 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2009 | 442 | 0.030 |
Why?
|
| Disease Progression | 2 | 2009 | 547 | 0.030 |
Why?
|
| Hospitals, Military | 1 | 2014 | 1 | 0.030 |
Why?
|
| Empathy | 1 | 2014 | 33 | 0.030 |
Why?
|
| Communication | 1 | 2014 | 96 | 0.020 |
Why?
|
| Safety | 2 | 2002 | 35 | 0.020 |
Why?
|
| Diet, Reducing | 1 | 2009 | 12 | 0.020 |
Why?
|
| Morbidity | 1 | 2009 | 50 | 0.020 |
Why?
|
| Evidence-Based Practice | 1 | 2009 | 53 | 0.020 |
Why?
|
| Energy Intake | 1 | 2009 | 77 | 0.020 |
Why?
|
| Young Adult | 1 | 2014 | 1659 | 0.020 |
Why?
|
| Metabolic Syndrome | 1 | 2009 | 55 | 0.020 |
Why?
|
| Life Style | 1 | 2009 | 167 | 0.020 |
Why?
|
| Injections, Epidural | 1 | 2004 | 15 | 0.010 |
Why?
|
| Angelica sinensis | 1 | 2003 | 1 | 0.010 |
Why?
|
| Cimicifuga | 1 | 2003 | 1 | 0.010 |
Why?
|
| Soy Foods | 1 | 2003 | 1 | 0.010 |
Why?
|
| Isoflavones | 1 | 2003 | 2 | 0.010 |
Why?
|
| Phytoestrogens | 1 | 2003 | 4 | 0.010 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2003 | 5 | 0.010 |
Why?
|
| Vitamin E | 1 | 2003 | 38 | 0.010 |
Why?
|
| Patient Education as Topic | 1 | 2003 | 121 | 0.010 |
Why?
|
| Liver Function Tests | 1 | 2002 | 21 | 0.010 |
Why?
|
| Electric Impedance | 1 | 2002 | 24 | 0.010 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2002 | 49 | 0.010 |
Why?
|
| Viral Load | 1 | 2002 | 70 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2002 | 106 | 0.010 |
Why?
|